Literature DB >> 10438921

Cytolytic T lymphocyte-associated antigen-4 and the TCR zeta/CD3 complex, but not CD28, interact with clathrin adaptor complexes AP-1 and AP-2.

H Schneider1, M Martin, F A Agarraberes, L Yin, I Rapoport, T Kirchhausen, C E Rudd.   

Abstract

The negative signaling receptor cytolytic T lymphocyte-associated Ag-4 (CTLA-4) resides primarily in intracellular compartments such as the Golgi apparatus of T cells. However, little is known regarding the molecular mechanisms that influence this accumulation. In this study, we demonstrate binding of the clathrin adaptor complex AP-1 with the GVYVKM motif of the cytoplasmic domain of CTLA-4. Binding occurred primarily in the Golgi compartment of T cells, unlike with AP-2 binding that occurs mostly with cell surface CTLA-4. Although evidence was not found to implicate AP-1 binding in the retention of CTLA-4 in the Golgi, AP-1 appears to play a role in shuttling of excess receptor from the Golgi to the lysosomal compartments for degradation. In support of this, increased CTLA-4 synthesis resulted in an increase in CTLA-4/AP-1 binding and a concomitant increase in the appearance of CTLA-4 in the lysosomal compartment. At the same time, the level of intracellular receptor was maintained at a constant level, suggesting that CTLA-4/AP-1 binding represents one mechanism to ensure steady state levels of intracellular CTLA-4 in T cells. Finally, we demonstrate that the TCR zeta/CD3 complex (but not CD28) also binds to AP-1 and AP-2 complexes, thus providing a possible link between these two receptors in the regulation of T cell function.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10438921

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

1.  Mechanism for down-regulation of CD28 by Nef.

Authors:  T Swigut; N Shohdy; J Skowronski
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

Review 2.  Blockade of cytotoxic T-lymphocyte antigen-4 as a new therapeutic approach for advanced melanoma.

Authors:  Xiang-Yang Wang; Daming Zuo; Devanand Sarkar; Paul B Fisher
Journal:  Expert Opin Pharmacother       Date:  2011-12       Impact factor: 3.889

Review 3.  CTLA-4 and tolerance: the biochemical point of view.

Authors:  Shunsuke Chikuma; Jeffrey A Bluestone
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

4.  Unexpected role of clathrin adaptor AP-1 in MHC-dependent positive selection of T cells.

Authors:  Diana A Alvarez Arias; Nami McCarty; Linrong Lu; Roberto A Maldonado; Mari L Shinohara; Harvey Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-25       Impact factor: 11.205

5.  The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses.

Authors:  Lucy S K Walker; David M Sansom
Journal:  Nat Rev Immunol       Date:  2011-11-25       Impact factor: 53.106

Review 6.  At the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy.

Authors:  Andrew M Intlekofer; Craig B Thompson
Journal:  J Leukoc Biol       Date:  2013-04-26       Impact factor: 4.962

7.  Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection.

Authors:  Jeffrey E Teigler; Gennadiy Zelinskyy; Michael A Eller; Diane L Bolton; Mary Marovich; Alexander D Gordon; Aljawharah Alrubayyi; Galit Alter; Merlin L Robb; Jeffrey N Martin; Steven G Deeks; Nelson L Michael; Ulf Dittmer; Hendrik Streeck
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

Review 8.  Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family.

Authors:  Frank A Schildberg; Sarah R Klein; Gordon J Freeman; Arlene H Sharpe
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

9.  CTLA-4 disrupts ZAP70 microcluster formation with reduced T cell/APC dwell times and calcium mobilization.

Authors:  Helga Schneider; Xin Smith; Hebin Liu; Georges Bismuth; Christopher E Rudd
Journal:  Eur J Immunol       Date:  2008-01       Impact factor: 5.532

10.  Activation-induced accumulation of B and T lymphocyte attenuator at the immunological synapse in CD4+ T cells.

Authors:  Takayoshi Owada; Norihiko Watanabe; Mie Oki; Yoshihiro Oya; Yasushi Saito; Takashi Saito; Itsuo Iwamoto; Theresa L Murphy; Kenneth M Murphy; Hiroshi Nakajima
Journal:  J Leukoc Biol       Date:  2009-11-05       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.